• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2742-9
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/19/2017
Event Type  malfunction  
Manufacturer Narrative
A supplemental medwatch report will be submitted upon completion of the investigation.
 
Event Description
A hemodialysis (hd) nurse reported during hd treatment a patient had blood on his shirt and under his arm due to a leak noted at the blue venous needle port.Additional follow-up revealed the hd patient was connected to a 2008k2 hd machine and had been dialyzing for approximately an hour and 20 minutes when a blood leak was noted at the blue venous needle port.The patient¿s dialysate flow rate (dfr) was 600 and the patient¿s blood flow rate (bfr) was 400.The rn stated the leak was noted as being an external blood leak at the blue venous needle port where the needle was to be ¿spiked in.¿ the rn stated the port had not yet been used and the exact location of the leak was unknown.Per rn the tubing line was taped to the patient¿s arm, and as such blood came into contact with the patient¿s arm and shirt.No visual damage to the bloodline was observed.The patient¿s estimated blood loss (ebl) was confirmed to be approximately 50ml.The rn stated the treatment was stopped immediately after the blood leak was noted and the patient¿s blood was returned to the patient.Per rn the patient was able to resume hemodialysis treatment the following treatment without further issue.The patient refused to continue hemodialysis treatment and signed an ama (against medical advice) form.The rn stated the patient was able to resume hemodialysis treatment the following session without further issue.The sample was available to be returned for evaluation.
 
Manufacturer Narrative
Plant investigation: the device was not returned to the manufacturer for physical evaluation and the failure mode cannot be confirmed.The entire lot has been sold and distributed.However, an investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances during the manufacturing process.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.
 
Event Description
A hemodialysis (hd) nurse reported during hd treatment a patient had blood on his shirt and under his arm due to a leak noted at the blue venous needle port.Additional follow-up revealed the hd patient was connected to a 2008k2 hd machine and had been dialyzing for approximately an hour and 20 minutes when a blood leak was noted at the blue venous needle port.The patient¿s dialysate flow rate (dfr) was 600 and the patient¿s blood flow rate (bfr) was 400.The rn stated the leak was noted as being an external blood leak at the blue venous needle port where the needle was to be ¿spiked in.¿ the rn stated the port had not yet been used and the exact location of the leak was unknown.Per rn the tubing line was taped to the patient¿s arm, and as such blood came into contact with the patient¿s arm and shirt.No visual damage to the bloodline was observed.The patient¿s estimated blood loss (ebl) was confirmed to be approximately 50ml.The rn stated the treatment was stopped immediately after the blood leak was noted and the patient¿s blood was returned to the patient.Per rn the patient was able to resume hemodialysis treatment the following treatment without further issue.The patient refused to continue hemodialysis treatment and signed an ama (against medical advice) form.The rn stated the patient was able to resume hemodialysis treatment the following session without further issue.The sample was available to be returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX   88780
Manufacturer Contact
thomas c. johnson
920 winter st.
waltham, MA 02451
7816999499
MDR Report Key7139386
MDR Text Key95801554
Report Number8030665-2017-01143
Device Sequence Number1
Product Code FJK
UDI-Device Identifier00840861100309
UDI-Public00840861100309
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Catalogue Number03-2742-9
Device Lot Number17LR01223
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device Age MO
Date Manufacturer Received01/30/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/24/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age54 YR
Patient Weight74
-
-